Back to Search
Start Over
Flecainide in Ventricular Arrhythmias: From Old Myths to New Perspectives
- Source :
- Journal of Clinical Medicine, Vol 10, Iss 16, p 3696 (2021)
- Publication Year :
- 2021
- Publisher :
- MDPI AG, 2021.
-
Abstract
- Flecainide is an IC antiarrhythmic drug (AAD) that received in 1984 Food and Drug Administration approval for the treatment of sustained ventricular tachycardia (VT) and subsequently for rhythm control of atrial fibrillation (AF). Currently, flecainide is mainly employed for sinus rhythm maintenance in AF and the treatment of idiopathic ventricular arrhythmias (IVA) in absence of ischaemic and structural heart disease on the basis of CAST data. Recent studies enrolling patients with different structural heart diseases demonstrated good effectiveness and safety profile of flecainide. The purpose of this review is to assess current evidence for appropriate and safe use of flecainide, 30 years after CAST data, in the light of new diagnostic and therapeutic tools in the field of ischaemic and non-ischaemic heart disease.
Details
- Language :
- English
- ISSN :
- 20770383
- Volume :
- 10
- Issue :
- 16
- Database :
- Directory of Open Access Journals
- Journal :
- Journal of Clinical Medicine
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.036737f37f5a460d9dba52be2223682c
- Document Type :
- article
- Full Text :
- https://doi.org/10.3390/jcm10163696